COVID-19 Vaccine for Children after MIS-C Appears Safe

Published: 01/04/2023

  • Miscellaneous
Relevant To:
  • Urgent Care,
  • Medical Office,
  • Critical Access Hospitals,
  • Hospitals,
  • Ambulatory Care,
  • Rural Health Clinics

According to a new study sponsored by the National Institutes of Health, children and adolescents who received a COVID-19 vaccination following multisystem inflammatory syndrome (MIS-C) found that there were no reports of serious complications, including myocarditis or MIS-C reoccurrence. About half of participants experienced mild and typical reactions, including arm soreness and fatigue. The findings will publish today in JAMA Network Open.

The multicenter, observational study, the largest

Sign Up for Free Trial